scispace - formally typeset
Y

Yujia Guo

Researcher at Shanxi Medical University

Publications -  14
Citations -  382

Yujia Guo is an academic researcher from Shanxi Medical University. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 7, co-authored 12 publications receiving 137 citations.

Papers
More filters
Journal ArticleDOI

circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway

TL;DR: This study reveals that the novel autophagy-suppressive circPARD3 promotes LSCC progression and chemoresistance through the PRKCI-Akt-mTOR pathway, providing new insights into circRNA-mediated autophagic regulation and potential biomarker and target for LSCC treatment.
Journal ArticleDOI

Crosstalk between RNA m6A Modification and Non-coding RNA Contributes to Cancer Growth and Progression.

TL;DR: The functional crosstalk between m6A and non-Coding RNAs, particularly microRNA, long non-coding RNA, and circular RNA, is described, and their roles in tumor regulation are illustrated.
Journal ArticleDOI

Effect of HPV Infection on the Occurrence and Development of Laryngeal Cancer: A Review.

TL;DR: Research progress in investigating HPV infection in terms of DNA, mRNA and protein levels in the occurrence and development of laryngeal cancer and routine HPV detection methods is reviewed.
Journal ArticleDOI

Fascin actin-bundling protein 1 in human cancer: promising biomarker or therapeutic target?

TL;DR: Fascin actin-bundling protein 1 (FSCN1) as discussed by the authors is a highly conserved actin bundling protein that cross links F-actin microfilaments into tight, parallel bundles and is recognized as a candidate biomarker for multiple cancer types and as a potential therapeutic target.